Healthcare
Wellgistics Health, Inc.(WGRX)
Live Price
Offline$3.72
-0.53% today
1Y Change
-93.50%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- $10.00M
- Revenue Growth
- +28.7%
- EPS Growth
- -1000.0%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Wellgistics Health, Inc. (WGRX) is a Healthcare stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $3.72 and down 93.5% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +28.7%, EPS growth of -1000.0%, a dividend yield of 0.0%. What stands out right now is revenue +28.7%, EPS -1000.0%, free cash flow -577.5% with operating margin -347.9% and ROIC -669.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines WGRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+28.7% vs +7.6% peer median
Operating Margin
Below sector median
-347.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +28.7% and EPS is at -1000.0%, with operating margin around -347.9%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +24.0% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | -14.1% | +89.1% | -21.1% |
2026 Mar 20, 2026 | โ | -8.0% | -26.3% | -3.6% |
2025 Nov 19, 2025 | โ | -15.5% | +9.2% | -17.3% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WGRX
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
WGRX Max Drawdown
-96.35%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for WGRX and SPY.
Company Overview
Wellgistics Health, Inc.
NASDAQ Capital Market
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
- Leadership
- Prashant Patel
- IPO Date
- Feb 25, 2025
- Employees
- 31
- Street Address
- 3000 Bayport Drive
- Mailing
- Tampa, FL, 33607
- Region
- Tampa, FL, US
- Reporting Currency
- USD
- Investor Line
- 844 203 6092
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.3
- Price/Book
- โ
Growth
- Revenue
- +28.7%
- EPS
- -1000.0%
- Free Cash Flow
- -577.5%
Profitability
- Gross Margin
- -41.3%
- Operating Margin
- -347.9%
- Net Margin
- -433.9%
- ROE
- 141760.2%
- ROIC
- -669.0%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.09
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.